TrialBMJ open2022

Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trial.

Jean-Baptiste Trouiller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.